TickerFactsScreenerDevelopers

NovaBridge Biosciences (NBP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: 1.59B CNY2019: 1.14B CNY2020: 4.76B CNY2021: 3.52B CNY2022: 3.21B CNY2023: 2.14B CNY2.14B CNY
2018Cash & Equivalents (CNY)2023
Fiscal YearCash & EquivalentsChange YoY
20232.14B CNY-33.4%
20223.21B CNY-8.8%
20213.52B CNY-26.0%
20204.76B CNY+318.4%
20191.14B CNY-28.4%
20181.59B CNY—